| Literature DB >> 26378999 |
Monika Pankowska-Supryn1, Monika Załęska, Barbara Roszkowska-Śliż, Kazimierz Roszkowski-Śliż.
Abstract
Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer.Entities:
Keywords: breast cancer; docetaxel; interstitial lung disease
Mesh：
Substances：
Year: 2015 PMID： 26378999 DOI： 10.5603/PiAP.2015.0060
Source DB: PubMed Journal: Pneumonol Alergol Pol ISSN： 0867-7077